Brief: United Laboratories International Says Unit Got Notice On Acceptance Of Clinical Trial Registration Issued By China's Nmpa About Semaglutide Injection
17/08/2022 15:14
Aug 17 (Reuters) - United Laboratories International
Holdings Ltd 3933.HK :
* UNIT GOT NOTICE ON ACCEPTANCE OF CLINICAL TRIAL
REGISTRATION
ISSUED BY CHINA'S NMPA ABOUT SEMAGLUTIDE INJECTION
Further company coverage: 3933.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million